Laurus Labs Hits New 52-Week High of Rs. 974.35, Surges 2.08%
Laurus Labs has achieved a new 52-week high, reflecting strong performance in the pharmaceuticals sector. The company reported a remarkable net profit growth of 993.4% in its latest quarterly results and has delivered a 94.86% return over the past year, significantly outperforming the Sensex.
Laurus Labs has reached a significant milestone by hitting a new 52-week high of Rs. 974.35 today, marking a notable achievement in the pharmaceuticals and biotechnology sector. This price reflects a 2.08% increase during the trading session, showcasing the stock's strong performance relative to its sector, outperforming by 1.07%.The company has demonstrated impressive financial metrics, with a remarkable net profit growth of 993.4% reported in its latest quarterly results. Over the past year, Laurus Labs has delivered an exceptional return of 94.86%, significantly outpacing the Sensex, which has only seen a 5.12% increase in the same period. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a robust upward trend.
Despite some concerns regarding its high Debt to EBITDA ratio of 3.74 times, Laurus Labs has maintained strong institutional support, with holdings at 37.63%. This combination of strong performance indicators and market position highlights Laurus Labs' current standing in the competitive landscape of the pharmaceuticals and biotechnology industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
